Today: 20 May 2026
China PMI slip puts ESWIN Material’s 688783 A-shares in focus before Shanghai open
2 February 2026
1 min read

China PMI slip puts ESWIN Material’s 688783 A-shares in focus before Shanghai open

Shanghai, Feb 2, 2026, 09:18 (GMT+8) — Premarket

Xi’an ESWIN Material Technology Co., Ltd.’s A-shares (688783.SS) face pressure ahead of Monday’s open following a drop in China’s official factory gauge back into contraction. The decline could hit chip-supply stocks linked to utilisation rates and pricing.

The company produces 12-inch silicon wafers, the core material chipmakers slice into thousands of dies. Demand usually mirrors shifts in production schedules at foundries and memory manufacturers. Investors frequently rely on macro factory data as an early, rough signal of how intensively chip fabs will operate in coming months.

ESWIN made its debut on the Shanghai Stock Exchange’s STAR Market on Oct. 28, pricing its IPO at 8.62 yuan. Attention now shifts to whether the company’s growth can outpace its losses in the early days after listing.

The stock ended at 26.29 yuan on Jan. 30, slipping 0.79% that day. It dropped 1.39% over the last five sessions but remains up 10.46% year-to-date, according to MarketScreener data.

In a Jan. 21 filing, the company projected 2025 revenue around 2.65 billion yuan, marking a 24.91% increase from the previous year. However, it also forecast a net loss attributable to shareholders near 738 million yuan, essentially flat compared to 2024.

The macro backdrop hasn’t been kind. The official PMI slipped to 49.3 in January from 50.1 in December, with both new and export orders showing further declines; the survey marks 50 as the dividing line between expansion and contraction. Huo Lihui, a statistician at China’s National Bureau of Statistics, noted market demand remains soft. Meanwhile, Nomura’s Ting Lu cautioned that policymakers might need to ramp up stimulus, saying, “Beijing will have to do much more” to keep growth above 4.5% in 2026. Reuters

Traders are eyeing the private Caixin/RatingDog manufacturing PMI set for release Monday. The median forecast on Investing.com’s calendar sits at 50.3 for January, slightly up from 50.1 before.

The downside is clear: weaker orders and fresh price wars could push back profit gains for wafer suppliers still expanding capacity and qualifying customers, particularly if chipmakers focus on inventory rather than new production. Policymakers have stepped in to limit steep price cuts in some industrial sectors, signaling pressure on margins.

Traders are eyeing ESWIN’s 2025 annual report due April 21. It’s expected to shed light on margins, cash burn, and how fast increased output is boosting earnings.

Stock Market Today

  • SpaceX IPO Filing Could Propel Elon Musk to Trillionaire Status
    May 20, 2026, 5:46 PM EDT. SpaceX's recent S-1 filing signals a potential initial public offering (IPO) that could surpass the 2020 record set by Saudi Aramco as the largest IPO in history. The deal is expected to significantly increase the valuation of SpaceX, potentially making CEO Elon Musk a trillionaire. This move highlights the growing investor interest in private spaceflight companies and the expanding market for space exploration-related ventures.

Latest articles

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

20 May 2026
Xanadu Quantum Technologies’ shares surged 20.4% to $14.13 Wednesday, rebounding after a sharp May decline. The company reported Q1 revenue of $2.83 million and a net loss of $20.6 million, with 43.3 million Class B shares outstanding and a prospectus covering up to 293.7 million more. Other quantum stocks also rose. Xanadu is in talks for up to $285 million in Canadian government support.
MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
Marvell stock slides to $78.92 — what MRVL investors watch as payrolls, tech earnings loom
Previous Story

Marvell stock slides to $78.92 — what MRVL investors watch as payrolls, tech earnings loom

Winbond stock tumbles 8% at the open as Taiwan’s memory trade turns choppy again
Next Story

Winbond stock tumbles 8% at the open as Taiwan’s memory trade turns choppy again

Go toTop